ITGAM and neoplasm: GL261 GBM tumor bearing p65KO and control mice were analyzed for p65 loss in the myeloid compartment using tissue-based immunofluorescence, which identified decreased CD11b+ cells as well as decreased p65 protein expression in CD11b+ cells in p65KO compared to control mice (Fig. 1B).